Full text
PDFPage 688
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ASBOE-HANSEN G. Endocrine control of connective tissue. Am J Med. 1959 Mar;26(3):470–484. doi: 10.1016/0002-9343(59)90252-9. [DOI] [PubMed] [Google Scholar]
- ASBOE-HANSEN G. The pathogenesis of cutaneous myxedema. Arch Dermatol. 1960 Jul;82:32–34. doi: 10.1001/archderm.1960.01580010038005. [DOI] [PubMed] [Google Scholar]
- Bland J. H., Frymoyer J. W. Rheumatic syndromes of myxedema. N Engl J Med. 1970 May 21;282(21):1171–1174. doi: 10.1056/NEJM197005212822103. [DOI] [PubMed] [Google Scholar]
- Kastin A. J., Ehrensing R. H., Schalch D. S., Anderson M. S. Improvement in mental depression with decreased thyrotropin response after administration of thyrotropin-releasing hormone. Lancet. 1972 Oct 7;2(7780):740–742. doi: 10.1016/s0140-6736(72)92028-4. [DOI] [PubMed] [Google Scholar]
- Mountjoy C. Q., Price J. S., Weller M., Hunter P., Hall R., Dewar J. H. A double-blind crossover sequential trial of oral thyrotrophin-releasing hormone in depression. Lancet. 1974 May 18;1(7864):958–960. doi: 10.1016/s0140-6736(74)91263-x. [DOI] [PubMed] [Google Scholar]